FT
Schedule 13G filing
FIRST TRUST PORTFOLIOS LP disclosed a 11.3% stake in abrdn Life Sciences Investors (HQL)
FIRST TRUST PORTFOLIOS LP reported owning 11.3% of abrdn Life Sciences Investors (HQL) (3,551,582 shares) in a Schedule 13G filed Oct 14, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 14, 2026
- Source
- Schedule 13G
More HQL insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.